Evaluation of oncology hospital at home: unplanned health care utilization and costs in the huntsman at home real-world trial
PURPOSE Patients with cancer experience high rates of morbidity and unplanned health
care utilization and may benefit from new models of care. We evaluated an adult oncology …
care utilization and may benefit from new models of care. We evaluated an adult oncology …
Design of an interface to communicate artificial intelligence-based prognosis for patients with advanced solid tumors: a user-centered approach
…, K Kawamoto, EA Sloss, JP McPherson - Journal of the …, 2024 - academic.oup.com
Objectives To design an interface to support communication of machine learning (ML)-based
prognosis for patients with advanced solid tumors, incorporating oncologists’ needs and …
prognosis for patients with advanced solid tumors, incorporating oncologists’ needs and …
A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome
J Marsiglio, JP McPherson… - Frontiers in …, 2023 - frontiersin.org
Background Type 1 diabetes mellitus (T1DM) is a rare, but serious immune-related adverse
event (irAE) of immune checkpoint inhibitors (ICIs). Our goal was to characterize treatment …
event (irAE) of immune checkpoint inhibitors (ICIs). Our goal was to characterize treatment …
[HTML][HTML] Real-world experience with elective discontinuation of PD-1 inhibitors at 1 year in patients with metastatic melanoma
R Pokorny, JP McPherson, B Haaland… - … for immunotherapy of …, 2021 - ncbi.nlm.nih.gov
Background Randomized trials evaluating programmed cell death protein 1 (PD-1) inhibitors
in metastatic melanoma either permitted treatment for 2 years (pembrolizumab) or more (…
in metastatic melanoma either permitted treatment for 2 years (pembrolizumab) or more (…
External validation of a machine learning model to predict 6-month mortality for patients with advanced solid tumors
G Chalkidis, JP McPherson, A Beck… - JAMA Network …, 2023 - jamanetwork.com
Machine learning (ML)–based prognosis has shown promise in enabling serious illness
conversations. 1 To facilitate effective conversations at treatment decision points (TDPs) …
conversations. 1 To facilitate effective conversations at treatment decision points (TDPs) …
[HTML][HTML] Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4+ naïve T cells at baseline are associated with severe immune …
…, A Erickson-Wayman, JP McPherson… - … for Immunotherapy of …, 2024 - ncbi.nlm.nih.gov
Original research: Lower frequencies of circulating suppressive regulatory T cells and
higher frequencies of CD4+ naïve T cells at baseline are associated with severe immune-related …
higher frequencies of CD4+ naïve T cells at baseline are associated with severe immune-related …
A phase I clinical trial of the effect of belinostat on the pharmacokinetics and pharmacodynamics of warfarin
N Agarwal, JP McPherson, H Bailey, S Gupta… - Cancer chemotherapy …, 2016 - Springer
Purpose Belinostat is a potent small molecule inhibitor that exerts its antitumor effect
through inhibition of histone deacetylase. The purpose of this study was to evaluate the …
through inhibition of histone deacetylase. The purpose of this study was to evaluate the …
A phase I study to determine the pharmacokinetics and urinary excretion of belinostat and metabolites in patients with advanced solid tumors
H Bailey, JP McPherson, EB Bailey, TL Werner… - Cancer chemotherapy …, 2016 - Springer
Purpose Belinostat is an inhibitor of histone deacetylase enzymes, resulting in DNA repair
inhibition and apoptosis. Present data are lacking to provide dosing recommendations in …
inhibition and apoptosis. Present data are lacking to provide dosing recommendations in …
The oncology hospital at home: Health care utilization outcomes from the huntsman at home trial.
7000 Background: Unplanned hospitalizations and emergency department (ED) visits are
common during cancer care. Providing acute hospital level care at home may add value by …
common during cancer care. Providing acute hospital level care at home may add value by …
Patient and Caregiver Perceptions of an Interface Design to Communicate Artificial Intelligence–Based Prognosis for Patients With Advanced Solid Tumors
PURPOSE Use of artificial intelligence (AI) in cancer care is increasing. What remains unclear
is how best to design patient-facing systems that communicate AI output. With oncologist …
is how best to design patient-facing systems that communicate AI output. With oncologist …